HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tetrandrine reverses human cardiac myofibroblast activation and myocardial fibrosis.

Abstract
Tetrandrine (TTD) is a calcium channel blocker with documented antifibrotic actions. In this study, for the first time, we identified that TTD can directly prevent in vitro human cardiac myofibroblast activation and limit in vivo myocardial fibrosis. In vitro, cardiac myofibroblasts from human atrial biopsies (N = 10) were seeded in three-dimensional collagen matrices. Cell-collagen constructs were exposed to transforming growth factor-β1 (10 ng/ml), with or without TTD (1 and 5 μM) for 48 h. Collagen gel contraction, myofibroblast activation (α-smooth muscle actin expression), expression of profibrotic mRNAs, and rate of collagen protein synthesis were compared. TTD decreased collagen gel contraction (79.7 ± 1.3 vs 60.1 ± 8.9%, P < 0.01), α-smooth muscle actin expression (flow cytometry), collagen synthesis ([(3)H]proline incorporation), and collagen mRNA expression. Cell viability was similar between groups (annexin positive cells: 1.7 vs. 1.4%). TTD inhibited collagen gel contraction in the presence of T-type and L-type calcium channel blockers, and the intracellular calcium chelator BAPTA-AM (15 μM), suggesting that the observed effects are not mediated by calcium homeostasis. In vivo, Dahl salt-sensitive hypertensive rats were treated with variable doses of TTD (by intraperitoneal injection over 4 wk) and compared with untreated controls (N = 12). Systemic blood pressure was monitored by tail cuff. Myocardial fibrosis and left ventricular compliance were assessed by histology and passive pressure-volume analysis. Myocardial fibrosis was attenuated compared with untreated controls (%collagen area: 9.4 ± 7.3 vs 2.1 ± 1.0%, P < 0.01). Left ventricular compliance was preserved. In conclusion, TTD reverses human cardiac myofibroblast activation and myocardial fibrosis, independent of calcium channel blockade.
AuthorsGuoqi Teng, Daniyil Svystonyuk, Holly E M Mewhort, Jeannine D Turnbull, Darrell D Belke, Henry J Duff, Paul W M Fedak
JournalAmerican journal of physiology. Heart and circulatory physiology (Am J Physiol Heart Circ Physiol) Vol. 308 Issue 12 Pg. H1564-74 (Jun 15 2015) ISSN: 1522-1539 [Electronic] United States
PMID25862829 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 the American Physiological Society.
Chemical References
  • ACTA2 protein, human
  • Actins
  • Benzylisoquinolines
  • Calcium Channel Blockers
  • Calcium Chelating Agents
  • Gels
  • tetrandrine
  • Collagen
  • Calcium
Topics
  • Actins (genetics, metabolism)
  • Animals
  • Atrial Appendage (drug effects, metabolism, pathology)
  • Benzylisoquinolines (pharmacology)
  • Calcium (metabolism)
  • Calcium Channel Blockers (pharmacology)
  • Calcium Chelating Agents (pharmacology)
  • Cardiomyopathies (metabolism, pathology, physiopathology, prevention & control)
  • Cells, Cultured
  • Collagen (genetics, metabolism)
  • Dose-Response Relationship, Drug
  • Fibrosis
  • Gels
  • Humans
  • Hypertension (drug therapy, metabolism, pathology, physiopathology)
  • Male
  • Myofibroblasts (drug effects, metabolism, pathology)
  • Rats, Inbred Dahl
  • Time Factors
  • Ventricular Function, Left (drug effects)
  • Ventricular Remodeling (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: